Incretin & mitochondrial research
MOTS-c
Mitochondrial-derived peptide regulating AMPK
VY-MOT-2608-02Tested 2026-08-29
Purchase options
Price
$80
AUD · GST inclusive · $8 per mg
Quantity
1
Same-day dispatch
Orders before 2pm AEST
Tracked express post
Australia Post, 1–3 business days
Discreet packaging
Plain, unbranded outer box
Description
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene. Research examines its role as a metabolic regulator that translocates to the nucleus under stress and modulates AMPK activity, folate-methionine cycling and insulin sensitivity in skeletal muscle models.
Research notes
- First mitochondrial-derived peptide shown to regulate nuclear gene expression
- Studied in exercise-mimetic and age-related insulin resistance models
- Short sequence allows straightforward analytical verification
Research use only. This compound is supplied for in-vitro and laboratory research. It is not approved by the TGA or any regulatory body for human or veterinary use. Not for human consumption. Handle with appropriate laboratory precautions.
Specifications
- Purity (independent)
- 99.05%
- Molecular formula
- C101H152N28O22S2
- Molar mass
- 2174.6 g/mol
- CAS number
- 1627580-64-6
- Sequence
- MRWQEMGYIFYPRKLR
- Form
- Lyophilised powder
- Storage
- −20 °C
- Batch
- VY-MOT-2608-02
- Last tested
- 2026-08-29
